An impurity was found in Pfizer’s heart and blood pressure medication Accupril that has led to a recall of several lots of the drug. The contaminant, known as a nitrosamine, can be carcinogenic at high levels and can increase a patient’s risk of developing cancer over time.
Patients are advised against stopping their medication at this time. Rather, those that are concerned that they may have pills from ...
continue reading...
Drug manufacturer Pfizer has moved to recall several lots of blood pressure pills over concerns that the medication may have been tainted with a carcinogenic contaminant. The affected medications include Accuretic, which is a tablet distributed by Pfizer itself, as well as a line of medications distributed by a second manufacturer known as Greenstone. The Greenstone lots include a pill that combines quinapril hydrochloride and hydrochlorothiazide ...
Plaintiffs in valsartan-based drug lawsuits filed over possible carcinogenic contamination may have to make room for additional consumers as lawyers push for the inclusion of two other blood pressure medications, losartan and irbesartan. Batches of the drugs, in addition to valsartan, have been found to be tainted with NDMA, or nitrosodimethylamine. NDMA is a known human carcinogen and has been linked to the development of certain ...
The recall of valsartan batches contaminated with a chemical classified as a probable human carcinogen has extended to a sixth drug. As a result, Teva Pharmaceuticals has recalled a variety of valsartan-based medications manufactured by Mylan India.
The recall includes amlodipine-valsartan and amlodipine-valsartan-hydrochlorothiazide combination tablets. Like the other valsartan medications pulled off of shelves in recent recalls, the contamination appears to come from a ...
continue reading...
Recent news stories regarding certain heart medications also came with a startling warning: patients taking medications using the ingredient valsartan may have been unknowingly ingesting chemicals that could be carcinogenic. The issue stems from contamination of valsartan batches with chemicals that are generally used in a wide variety of industrial applications from making rocket fuel to processing fish.
The chemical at the center of the story, NDMA or N-nitrosodimethylamine, was ...
continue reading...
Plaintiffs involved in lawsuits over contamination of a key ingredient in generic heart medications have moved to have their cases consolidated before a federal judge.
Shipments of valsartan, an ingredient in medications used to treat high blood pressure and heart failure, were found to be tainted with a chemical known as NDMA. According to the EPA, NDMA is a possible human carcinogen and is used in ...
continue reading...
